Recruiting EARLY_PHASE1 Pain Management

New treatment option for Pain Management

Official title Ketamine for Shoulder Pain Following Laparoscopic Gastric Sleeve Surgery

ClinicalTrials.gov ID: NCT07429916

What this study is testing

What is Intraoperative ketamine?

Intraoperative ketamine is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for pain management.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
Shoulder pain is a well-recognized complaint following laparoscopic surgery. It is underlying mechanism has various causes, therefore, modalities in management and prevention of this sort of pain are numerous with different success rates.
  • Phase 1: an early, usually small safety study

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 60

You may be able to join if

  • patients aged 18-60
  • American society of anesthesiologist grade 1,2
  • BMI \> 40
  • BMI \> 35 with obesity-related comorbidities

You likely can't join if

  • mentally incapacitated
  • patients received any type of analgesia 24hr preoperatively except paracetamol
  • history of drug abuse
  • patients with low ejection fraction

The study team makes the final eligibility decision.

Where it's taking place

  • Irbid, Jordan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Irbid, Jordan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.